Amelioration of sexual behavior and motor activity deficits in a castrated rodent model with a selective androgen receptor modulator SARM-2f
Megumi Morimoto(Takeda (Japan)), Takahito Hara(Takeda (Japan)), Yuichiro Amano(Takeda (Japan)), Ryuichi Tozawa(National Institute of Infectious Diseases), Masahiro Oka(National Institute of Biomedical Innovation, Health and Nutrition), Masuo Yamaoka, Hisashi Fujita, Ayako Harada(Takeda (Japan)), Yukiko Hikichi(Takeda (Japan))
Cited by 19
Related Papers
Regulation of <i>Notch1</i> and <i>Dll4</i> by Vascular Endothelial Growth Factor in Arterial Endothelial Cells: Implications for Modulating Arteriogenesis and Angiogenesis
|Molecular and Cellular Biology|2002|502
Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
|PubMed|2003|427
Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response
|Proceedings of the National Academy of Sciences|2018|172
Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer
|Bioorganic & Medicinal Chemistry|2011|126
Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: Effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys
|The Journal of Steroid Biochemistry and Molecular Biology|2012|116